SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-21-000148
Filing Date
2021-11-12
Accepted
2021-11-12 08:07:24
Documents
78
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opnt-20210930.htm   iXBRL 10-Q 1115709
2 EX-31.1 exhibit31109302021.htm EX-31.1 11537
3 EX-31.2 exhibit31209302021.htm EX-31.2 11379
4 EX-32.1 exhibit32109302021.htm EX-32.1 5622
5 EX-32.2 exhibit32209302021.htm EX-32.2 5546
  Complete submission text file 0001385508-21-000148.txt   5689564

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20210930.xsd EX-101.SCH 44516
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20210930_cal.xml EX-101.CAL 50577
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20210930_def.xml EX-101.DEF 271451
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20210930_lab.xml EX-101.LAB 485065
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20210930_pre.xml EX-101.PRE 425597
11 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20210930_htm.xml XML 794936
Mailing Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD, SUITE 280 SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 211399764
SIC: 2834 Pharmaceutical Preparations